MX2024000653A - Un proceso para la sintesis de ester de butilo de acido 4-((r)-2-{[6-((s)-3-metoxi-pirrolidin-1-il)-2-fenil-pirimidin-4-c arbonil]-amino}-3-fosfono-propionil)-piperazin-1-carboxilico. - Google Patents
Un proceso para la sintesis de ester de butilo de acido 4-((r)-2-{[6-((s)-3-metoxi-pirrolidin-1-il)-2-fenil-pirimidin-4-c arbonil]-amino}-3-fosfono-propionil)-piperazin-1-carboxilico.Info
- Publication number
- MX2024000653A MX2024000653A MX2024000653A MX2024000653A MX2024000653A MX 2024000653 A MX2024000653 A MX 2024000653A MX 2024000653 A MX2024000653 A MX 2024000653A MX 2024000653 A MX2024000653 A MX 2024000653A MX 2024000653 A MX2024000653 A MX 2024000653A
- Authority
- MX
- Mexico
- Prior art keywords
- phosphono
- piperazine
- carbonyl
- methoxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2021069486 | 2021-07-13 | ||
| PCT/EP2022/069238 WO2023285342A2 (en) | 2021-07-13 | 2022-07-11 | A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024000653A true MX2024000653A (es) | 2024-01-31 |
Family
ID=82748669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024000653A MX2024000653A (es) | 2021-07-13 | 2022-07-11 | Un proceso para la sintesis de ester de butilo de acido 4-((r)-2-{[6-((s)-3-metoxi-pirrolidin-1-il)-2-fenil-pirimidin-4-c arbonil]-amino}-3-fosfono-propionil)-piperazin-1-carboxilico. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240317784A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370525A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024524658A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240033005A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117616033A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223733A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309948A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024000653A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202317140A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023285342A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2483072C2 (ru) | 2007-11-29 | 2013-05-27 | Актелион Фармасьютиклз Лтд | Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12 |
| CN109715639B (zh) | 2016-09-22 | 2022-04-19 | 爱杜西亚药品有限公司 | 结晶形式 |
| SG11201908128YA (en) | 2017-03-15 | 2019-10-30 | Idorsia Pharmaceuticals Ltd | Subcutaneous administration of a p2y12 receptor antagonist |
-
2022
- 2022-07-11 CA CA3223733A patent/CA3223733A1/en active Pending
- 2022-07-11 IL IL309948A patent/IL309948A/en unknown
- 2022-07-11 EP EP22748321.1A patent/EP4370525A2/en active Pending
- 2022-07-11 CN CN202280048853.5A patent/CN117616033A/zh active Pending
- 2022-07-11 KR KR1020247004672A patent/KR20240033005A/ko active Pending
- 2022-07-11 WO PCT/EP2022/069238 patent/WO2023285342A2/en not_active Ceased
- 2022-07-11 JP JP2024501708A patent/JP2024524658A/ja active Pending
- 2022-07-11 US US18/579,110 patent/US20240317784A1/en active Pending
- 2022-07-11 MX MX2024000653A patent/MX2024000653A/es unknown
- 2022-07-12 TW TW111126010A patent/TW202317140A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL309948A (en) | 2024-03-01 |
| KR20240033005A (ko) | 2024-03-12 |
| EP4370525A2 (en) | 2024-05-22 |
| CA3223733A1 (en) | 2023-01-19 |
| TW202317140A (zh) | 2023-05-01 |
| JP2024524658A (ja) | 2024-07-05 |
| US20240317784A1 (en) | 2024-09-26 |
| WO2023285342A3 (en) | 2023-04-13 |
| CN117616033A (zh) | 2024-02-27 |
| WO2023285342A2 (en) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4282416A3 (en) | Process of manufacture of a compound for inhibiting the activity of shp2 | |
| MX2024008497A (es) | Fabricacion de compuestos y composiciones para inhibir la actividad de shp2. | |
| WO2020016749A3 (en) | Chemical process for preparing phenylpiperidinyl indole derivatives | |
| MX2023012054A (es) | Inhibidor derivado heterociclico y metodo de preparacion y su aplicacion. | |
| MX2024011317A (es) | Procesos para la preparación de derivados sustituidos de espirooxindol. | |
| GB201100181D0 (en) | Fused aminodihydrothiazine derivatives | |
| SA523451905B1 (ar) | Cdk2 مركبات بيريميدينيل-بيرازول بها استبدال كمثبطات | |
| CA2665931C (en) | Hydrobenzamide derivatives as inhibitors of hsp90 | |
| CR20240352A (es) | Compuestos de uracilo sustituidos por n3 como inhibidores de trpa1 | |
| MEP0908A (xx) | Derivati pirimidina za tretman neprirodnog rasta ćelija | |
| NZ597538A (en) | Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives | |
| PH12022550777A1 (en) | Compound as small molecule inhibitor pd-1/pd-l1 and application thereof | |
| MX2023010125A (es) | Inhibidores del sarcomero cardiaco. | |
| MX2023000970A (es) | Metodo de preparacion de aminofuranos. | |
| MX2022013890A (es) | Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos. | |
| WO2022198062A3 (en) | Derivatives of substituted morpholines and uses thereof | |
| MX2025004635A (es) | Sal y forma cristalina de derivado heterociclico inhibidor, y metodo de preparacion y uso de las mismas | |
| MX2022010957A (es) | Compuestos que se dirigen a las proteínas de unión al arn o a las proteínas modificadoras del arn. | |
| MX2025010256A (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| MX2024012267A (es) | Inhibidores de egfr | |
| WO2020132471A8 (en) | Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof | |
| WO2024151638A3 (en) | Compounds for fgfrs inhibitors | |
| MX2025009371A (es) | Forma cristalina de derivado de sulfonamida y metodo de preparacion para ello | |
| WO2023150291A3 (en) | Heterocyclic compounds and methods of use | |
| WO2023285342A3 (en) | A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester |